Le guide intitulé « Autorisation d’accès précoce aux médicaments : doctrine d’évaluation de la HAS », ci-joint, est adopté.
eNrtWN9v2jAQfu9fgfLuhKQwwhSoNtZuSKvGaNGmvSBjH2Bm4tQ/gO6vn0NgwJSsa2je+oKCz7472999d+foarPktRVIxUTccXy37tQgJoKyeNZxRvc3KHSuuhfRAq/wYVpg57m+79QIx0p1nFTqTgDHyv1++/kD2PUgne5FLRKTBRB9Ms9oxt1PWM1vcZLOqUUrwWhtCXouaMdJjN6O1iKlpfWiuxbyp0owgcjbjRxLF+PG8Xjkpcr+Q6tRID/jeJardCpL6SRGSoh1D2uYCfmYqzqR1B8H7fCN3w5LGWFqCEoYSWCA9XwgxYpRoPnbwFxBKSPTNb0DueKgUyO5yr0FWapSyvECb4bw0M93+p2V9vRGozryW2HYbNbDpt+qN0uZkkdHlQ8fuwkvGV9eNup+w/em0qNAWIpyFKOgHgSo7gdtjxJPwRJRg4IQ4ZVkPBPaASI4hxkgCohjNMdGA7I/QjK9HVQ4th+JkNp+IExFolPtduXM2JtDLNZMG75fpHAmRpgQUCiRNphIKtygJVBG8NIiTCEqSLoBawHBCnOzW7XzQZVE1iD1kleEKaZ6p/FRkR0JD09ilzKVcPzoLlRS9qiwtFehQVoWq24j6Q7upeVVbs/sL/2x4dx7ptejHetV5HFKqj1hYl1AfjfDsgfREzaKNsU3Wo6v9WaHRQbq5dT+EnF+rhqYCWekLCFbyjSg9GjYL+bjVyrbI/09VjCS1XHZNxZTsVYvz5HHmKzI++0N8nylZByErWa7Vb6q+mHhX5Dbr40UCXiWO5k6hxL78VScS4Y2ovJV7ePpNZQOhbIgmENBqYxKsrqNoX1lX1mUVscAmSBX6cfr+7Lg/mpAPt5t/+aqZrTzB5blUl4VedSGUqHjzw/MjJ3+2URlLNUIL8u1UEbmk99c60S99bz1eu3acMmC1LXR/5paT1LUAUPVtZ+VFHxZAZwlqIpcn2R1x/PwVZYunioJz21zdut37VSuDS0NnHEXWWapjP/71y+fUg49TmVuD04osDoz235kSwpVVZpmkv8KdlYSs/ca30hLEF+mU1bwLliIy8jL3iS7F5GXvkd2L34DMLX4OA==
Vj9KF11E3dKQJYwf